CVS Health Corp. (NYSE:CVS) on Tuesday reported fourth-quarter fiscal 2025 results.
The company reported sales of $105.69 billion, beating the consensus of $103.59 billion. Total revenues increased 8.2% year-over-year, driven by revenue growth across all segments.
Adjusted earnings of $1.09 per share also beat the analyst estimate of 99 cents, decreased from $1.19 in the prior year, primarily due to a decline in adjusted operating income in the Health Care Benefits segment, reflecting changes in the seasonality of the Medicare Part D program due to the impact of the Inflation Reduction Act (IRA).
Adjusted operating income decreased 4.8% to $2.59 billion.
Segment Performance
Revenues in the Health Care Benefits segment increased 10.1% to $36.29 billion, primarily driven by increases in the Government business, largely due to the impact of the IRA on the Medicare Part D program.
Health Services segment …